logo

For the Inventor, By the Inventor

Middlesex, United Kingdom

Domantis Limited


USPTO Granted Patents = 38



Forward Citations = 429

Loading Chart...
Loading Chart...

56 inventors (with patents filed for the assignee):

goldMedal Suzanne J Suchard (15 out of 25 patents)

silverMedal Olga Ignatovich (13 out of 18 patents)

bronzeMedal Steven Grant (13 out of 20 patents)

4.  Ian M Tomlinson (13 out of 20 patents)

5.  Steven G Nadler (12 out of 21 patents)

6.  Steve Holmes (11 out of 26 patents)

7.  James K Tamura (9 out of 11 patents)

8.  James William Bryson (9 out of 19 patents)

9.  Philip Drew (9 out of 9 patents)

10.  Anish Suri (9 out of 9 patents)

11.  Aaron Paul Yamniuk (9 out of 33 patents)

12.  Laura Price (6 out of 9 patents)

13.  Robert P Rehfuss (6 out of 10 patents)

14.  Brendan Classon (6 out of 6 patents)

15.  Christopher Plummer (6 out of 7 patents)


38 patents:

1. 12012452 - Compositions monovalent for CD28 binding and methods of use (2024-06-18),
2. 11180567 - Antibody polypeptides that antagonize CD40L (2021-11-23),
3. 11136406 - Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40 (2021-10-05),
4. 10919965 - Compositions monovalent for CD28 binding and methods of use (2021-02-16),
5. 10544228 - Nucleic acids encoding antibody polypeptides that antagonize CD40 (2020-01-28),
6. 10196451 - Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L (2019-02-05),
7. 10072089 - Polypeptides, antibody variable domains and antagonists (2018-09-11),
8. 9908937 - Compositions monovalent for CD28 binding and methods of use (2018-03-06),
9. 9765150 - Antibody polypeptides that antagonize CD40L (2017-09-19),
10. 9629909 - Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue (2017-04-25),
11. 9562090 - Polypeptides, antibody variable domains and antagonists (2017-02-07),
12. 9475879 - Antibody polypeptides that antagonize CD40 (2016-10-25),
13. 9321832 - Ligand (2016-04-26),
14. 9228018 - Antibody polypeptides that antagonize CD40L (2016-01-05),
15. 9085629 - Compositions monovalent for CD28 binding and methods of use (2015-07-21),
Domantis Limited is a biotechnology company specializing in the development of novel antibody-based drugs. The company is known for its unique domain antibody platform, which allows for the creation of smaller, more stable therapeutic antibodies. Domantis aims to address unmet medical needs by creating innovative treatments for various diseases, including cancer, autoimmune disorders, and infectious diseases.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

38 Patents

#10 in Middlesex

#458 in United Kingdom

#17,314 in the World

...
Middlesex, United Kingdom

Domantis Limited

Forward Citations = 429

56 inventors:

goldMedal Suzanne J Suchard (15 out of 25 patents)

silverMedal Olga Ignatovich (13 out of 18 patents)

bronzeMedal Steven Grant (13 out of 20 patents)

4.  Ian M Tomlinson (13 out of 20 patents)

5.  Steven G Nadler (12 out of 21 patents)

Please report any incorrect information to support@idiyas.com
Loading…